Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Auto-HSCT + Inaticabtagene Autoleucel in Adult High-Risk ALL
NCT06608342Phase 2Recruiting
- Sponsor
- Institute of Hematology and Blood Diseases Hospital
- Start
- Jun 2024
- Primary completion
- May 2026
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of inaticabtagene autoleucel in acute lymphoblastic leukemia (ALL), sponsored by Institute of Hematology and Blood Diseases Hospital. Started Jun 2024; status: recruiting.
02
Drugs
inaticabtagene autoleucel
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT06608342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06608342.